| HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study RK Heaton, DB Clifford, DR Franklin Jr, SP Woods, C Ake, F Vaida, ... Neurology 75 (23), 2087-2096, 2010 | 2666 | 2010 |
| Conditional Akaike information for mixed effects models F Vaida, S Blanchard Corrado Lagazio, Marco Marchi (Eds) 101, 2005 | 738 | 2005 |
| Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial RJ Ellis, W Toperoff, F Vaida, G Van Den Brande, J Gonzales, B Gouaux, ... Neuropsychopharmacology 34 (3), 672-680, 2009 | 622 | 2009 |
| CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy RJ Ellis, J Badiee, F Vaida, S Letendre, RK Heaton, D Clifford, AC Collier, ... Aids 25 (14), 1747-1751, 2011 | 515 | 2011 |
| Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study RK Heaton, DR Franklin Jr, R Deutsch, S Letendre, RJ Ellis, K Casaletto, ... Clinical Infectious Diseases 60 (3), 473-480, 2015 | 427 | 2015 |
| Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline I Grant, DR Franklin Jr, R Deutsch, SP Woods, F Vaida, RJ Ellis, ... Neurology 82 (23), 2055-2062, 2014 | 380 | 2014 |
| Continued high prevalence and adverse clinical impact of human immunodeficiency virus–associated sensory neuropathy in the era of combination antiretroviral therapy: the … RJ Ellis, D Rosario, DB Clifford, JC McArthur, D Simpson, T Alexander, ... Archives of neurology 67 (5), 552-558, 2010 | 367 | 2010 |
| Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy LA Cysique, F Vaida, S Letendre, S Gibson, M Cherner, SP Woods, ... Neurology 73 (5), 342-348, 2009 | 356 | 2009 |
| Proportional hazards model with random effects F Vaida, R Xu Statistics in medicine 19 (24), 3309-3324, 2000 | 342 | 2000 |
| Demographically corrected norms for African Americans and Caucasians on the hopkins verbal learning test–revised, brief visuospatial memory test–revised, stroop color and word … MA Norman, DJ Moore, M Taylor, D Franklin Jr, L Cysique, C Ake, ... Journal of clinical and experimental neuropsychology 33 (7), 793-804, 2011 | 296 | 2011 |
| Independent effects of HIV, aging, and HAART on brain volumetric measures BM Ances, M Ortega, F Vaida, J Heaps, R Paul JAIDS Journal of Acquired Immune Deficiency Syndromes 59 (5), 469-477, 2012 | 293 | 2012 |
| Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy I Everall, F Vaida, N Khanlou, D Lazzaretto, C Achim, S Letendre, ... Journal of neurovirology 15, 360-370, 2009 | 246 | 2009 |
| Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trial SM Hammer, F Vaida, KK Bennett, MK Holohan, L Sheiner, JJ Eron, ... Jama 288 (2), 169-180, 2002 | 206 | 2002 |
| Pathways to neurodegeneration: effects of HIV and aging on resting-state functional connectivity JB Thomas, MR Brier, AZ Snyder, FF Vaida, BM Ances Neurology 80 (13), 1186-1193, 2013 | 190 | 2013 |
| HIV infection and aging independently affect brain function as measured by functional magnetic resonance imaging BM Ances, F Vaida, MJ Yeh, CL Liang, RB Buxton, S Letendre, ... The Journal of infectious diseases 201 (3), 336-340, 2010 | 185 | 2010 |
| Total physical activity in relation to age, body mass, health and other factors in a cohort of Swedish men A Norman, R Bellocco, F Vaida, A Wolk International journal of obesity 26 (5), 670-675, 2002 | 167 | 2002 |
| Randomized trial of central nervous system–targeted antiretrovirals for HIV-associated neurocognitive disorder RJ Ellis, S Letendre, F Vaida, R Haubrich, RK Heaton, N Sacktor, ... Clinical Infectious Diseases 58 (7), 1015-1022, 2014 | 158 | 2014 |
| Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain BM Ances, D Sisti, F Vaida, CL Liang, O Leontiev, JE Perthen, RB Buxton, ... Neurology 73 (9), 702-708, 2009 | 155 | 2009 |
| Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients Q Ma, F Vaida, J Wong, CA Sanders, Y Kao, D Croteau, DB Clifford, ... Journal of neurovirology 22, 170-178, 2016 | 151 | 2016 |
| Impaired replication capacity of acute/early viruses in persons who become HIV controllers T Miura, ZL Brumme, MA Brockman, P Rosato, J Sela, CJ Brumme, ... Journal of virology 84 (15), 7581-7591, 2010 | 151 | 2010 |
